Annual Total Expenses
$1.12 B
+$36.20 M+3.35%
31 December 2022
Summary:
NuVasive annual total expenses is currently $1.12 billion, with the most recent change of +$36.20 million (+3.35%) on 31 December 2022. During the last 3 years, it has risen by +$36.20 million (+3.35%).NUVA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$290.01 M
-$5.92 M-2.00%
30 June 2023
Summary:
NuVasive quarterly total expenses is currently $290.01 million, with the most recent change of -$5.92 million (-2.00%) on 30 June 2023.NUVA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NUVA Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +3.4% | +2.3% |
| 5 y5 years | +6.8% | +5.3% |
NUVA Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -2.0% |
NuVasive Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $290.01 M(-2.0%) |
| Mar 2023 | - | $295.93 M(+3.1%) |
| Dec 2022 | $1.12 B(+3.3%) | $287.03 M(+6.0%) |
| Sept 2022 | - | $270.70 M(-5.0%) |
| June 2022 | - | $285.00 M(+3.3%) |
| Mar 2022 | - | $275.77 M(-2.7%) |
| Dec 2021 | $1.08 B(+8.2%) | $283.52 M(+3.9%) |
| Sept 2021 | - | $272.92 M(+0.1%) |
| June 2021 | - | $272.53 M(+7.6%) |
| Mar 2021 | - | $253.33 M(-3.8%) |
| Dec 2020 | $1.00 B(-4.5%) | $263.24 M(-0.7%) |
| Sept 2020 | - | $265.12 M(+10.9%) |
| June 2020 | - | $239.03 M(+2.6%) |
| Mar 2020 | - | $233.00 M(-15.4%) |
| Dec 2019 | $1.05 B(+4.8%) | $275.33 M(+5.6%) |
| Sept 2019 | - | $260.65 M(+0.2%) |
| June 2019 | - | $260.26 M(+3.8%) |
| Mar 2019 | - | $250.77 M(-3.1%) |
| Dec 2018 | $999.36 M(+10.3%) | $258.69 M(+6.5%) |
| Sept 2018 | - | $242.97 M(-2.9%) |
| June 2018 | - | $250.20 M(+1.1%) |
| Mar 2018 | - | $247.50 M(+5.1%) |
| Dec 2017 | $906.41 M(+4.9%) | $235.55 M(+9.3%) |
| Sept 2017 | - | $215.51 M(-5.9%) |
| June 2017 | - | $229.07 M(+1.2%) |
| Mar 2017 | - | $226.29 M(-3.5%) |
| Dec 2016 | $863.71 M(+23.4%) | $234.40 M(+9.0%) |
| Sept 2016 | - | $215.04 M(-0.8%) |
| June 2016 | - | $216.71 M(+9.7%) |
| Mar 2016 | - | $197.56 M(+8.5%) |
| Dec 2015 | $700.11 M(+1.4%) | $182.15 M(+5.9%) |
| Sept 2015 | - | $171.98 M(-1.6%) |
| June 2015 | - | $174.84 M(+0.5%) |
| Mar 2015 | - | $174.02 M(+4.6%) |
| Dec 2014 | $690.12 M(+5.8%) | $166.31 M(-4.2%) |
| Sept 2014 | - | $173.60 M(-1.0%) |
| June 2014 | - | $175.35 M(+0.3%) |
| Mar 2014 | - | $174.85 M(-0.5%) |
| Dec 2013 | $652.08 M(+13.7%) | $175.79 M(+11.5%) |
| Sept 2013 | - | $157.60 M(-4.9%) |
| June 2013 | - | $165.64 M(+8.2%) |
| Mar 2013 | - | $153.05 M(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $573.55 M(+13.3%) | $151.91 M(+11.9%) |
| Sept 2012 | - | $135.81 M(-3.9%) |
| June 2012 | - | $141.39 M(-2.1%) |
| Mar 2012 | - | $144.44 M(+1.9%) |
| Dec 2011 | $506.18 M(+13.5%) | $141.75 M(+15.2%) |
| Sept 2011 | - | $123.09 M(+1.3%) |
| June 2011 | - | $121.48 M(+1.4%) |
| Mar 2011 | - | $119.86 M(+1.6%) |
| Dec 2010 | $446.15 M(+24.3%) | $117.97 M(+6.5%) |
| Sept 2010 | - | $110.72 M(-0.5%) |
| June 2010 | - | $111.30 M(+4.8%) |
| Mar 2010 | - | $106.15 M(+3.4%) |
| Dec 2009 | $359.02 M(+39.7%) | $102.68 M(+15.6%) |
| Sept 2009 | - | $88.83 M(+5.7%) |
| June 2009 | - | $84.06 M(+0.7%) |
| Mar 2009 | - | $83.45 M(+18.5%) |
| Dec 2008 | $257.07 M(+49.9%) | $70.45 M(-3.7%) |
| Sept 2008 | - | $73.15 M(+25.9%) |
| June 2008 | - | $58.10 M(+4.9%) |
| Mar 2008 | - | $55.39 M(+12.4%) |
| Dec 2007 | $171.54 M(+29.8%) | $49.27 M(+17.0%) |
| Sept 2007 | - | $42.11 M(+3.6%) |
| June 2007 | - | $40.66 M(+2.9%) |
| Mar 2007 | - | $39.50 M(+13.9%) |
| Dec 2006 | $132.20 M(+62.8%) | $34.68 M(-3.9%) |
| Sept 2006 | - | $36.10 M(-16.1%) |
| June 2006 | - | $43.03 M(+49.0%) |
| Mar 2006 | - | $28.89 M(+24.4%) |
| Dec 2005 | $81.20 M(+51.1%) | $23.22 M(+9.8%) |
| Sept 2005 | - | $21.15 M(+7.6%) |
| June 2005 | - | $19.66 M(+14.5%) |
| Mar 2005 | - | $17.17 M(+10.5%) |
| Dec 2004 | $53.73 M(+64.6%) | $15.54 M(+17.8%) |
| Sept 2004 | - | $13.19 M(-0.6%) |
| June 2004 | - | $13.26 M(+13.0%) |
| Mar 2004 | - | $11.73 M(+293.9%) |
| Dec 2003 | $32.64 M(+20.4%) | - |
| June 2003 | - | $2.98 M(-4.6%) |
| Mar 2003 | - | $3.12 M |
| Dec 2002 | $27.11 M(+212.2%) | - |
| Dec 2001 | $8.69 M(-39.3%) | - |
| Dec 2000 | $14.32 M | - |
FAQ
- What is NuVasive annual total expenses?
- What is the all time high annual total expenses for NuVasive?
- What is NuVasive quarterly total expenses?
- What is the all time high quarterly total expenses for NuVasive?
What is NuVasive annual total expenses?
The current annual total expenses of NUVA is $1.12 B
What is the all time high annual total expenses for NuVasive?
NuVasive all-time high annual total expenses is $1.12 B
What is NuVasive quarterly total expenses?
The current quarterly total expenses of NUVA is $290.01 M
What is the all time high quarterly total expenses for NuVasive?
NuVasive all-time high quarterly total expenses is $295.93 M